Oncotarget is a peer-reviewed, open-access biomedical journal indexed in MEDLINE, PubMed, PMC, Scopus, and more.
Orchard Park, NY
Joined February 2016
- Tweets16.3K
- Following3.7K
- Followers3.4K
- Likes6.8K
Pinned Tweet
🔬 Scientific integrity is at the core of scholarly publishing.
A new editorial from Oncotarget highlights publishing industry trends, measurable journal comparisons, and future strategy.
🔗 doi.org/10.18632/oncotarget.…
#ScientificIntegrity #AcademicPublishing #OA #Research
ALT Figure 4: Post-tools era. Oncotarget versus Scientific Reports and PLOS One. The percentage of “High risk” articles identified by the tool “Argos” (as of 3/05/2026) in relation to the total number of articles published in a journal during a specific year in 2019–2025.
🎧 Listen to our #PressRelease on the #CaseReport "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer."
soundcloud.com/oncotarget/in…
#Cancer #Podcast #Audio #SoundCloud #PaperSpotlight #ColonCancer #Press #OA
🎥 #OncotargetShort:
Abstract #Video about the #CaseReport "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer." @BrownUniversity
🔗 bit.ly/4sJDAoV
#Cancer #ColonCancer #ColorectalCancer #Oncotarget
🔆 #PaperSpotlight:
Case Report: "WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer"
#PressRelease ⬇️
bit.ly/4dZGy2g
#Cancer #ColonCancer #Oncology #OA #PeerReviewed #Publishing #Oncotarget
Oncotarget retweeted
#PaperoftheDay: "A “two-hit” (chemo)therapy to improve checkpoint inhibition in cancer"
DOI ⬇️
doi.org/10.18632/oncoscience…
#Cancer #Oncology #Research #OpenAccess #Publishing #PeerReviewed #Journal
🎀 Oncotarget’s Special Collection on Breast Cancer:
oncotarget.com/collections/b…
#breastcancer #cancerresearch #openaccess #publishing
#PaperoftheDay: "Laryngeal leiomyosarcoma: A rare case report and literature review"
DOI ⬇️
doi.org/10.18632/oncotarget.…
#Cancer #Oncology #OpenAccess #Research #Publishing #PeerReviewed #Journal
✅ Read our #blog post about the #editorial perspective, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment."
#Summary ⬇️
oncotarget.org/2026/03/10/ca…
#cancer #TrendingWithImpact #Tcells #cancertherapy #perspective #openaccess #peerreview #journal #publishing #meded
🎥 Watch & subscribe to Oncotarget’s #YouTube channel for author #interviews and #video shorts!
Our Channel ⬇️
youtube.com/@OncotargetJourn…
🌐 Visit Oncotarget.net for insight from our distinguished #authors and for the latest #pressreleases by Oncotarget.
#openaccess #peerreviewed #oncology #cancer #researchpapers #science #medicine #medEd #OA #press
✅ Read our #blog post about the #research paper, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells."
#Summary ⬇️
oncotarget.org/2025/04/22/ne…
#cancer #p53 #trendingwithimpact #openaccess #publishing
💬 How to contact #Oncotarget:
oncotarget.com/contact/
#OA #PeerReviewed #Journal #Research #Cancer #Oncology #MedEd #Publishing
🩺 Oncotarget’s Special Collection on Pancreatic Cancer:
oncotarget.com/collections/p…
#pancreaticcancer #cancerresearch #cancer #collections #openacess #publishing
✅ Cancer cells interact closely with immune cells in the tumor microenvironment.
A recent #Oncotarget study examines how DHHC3 contributes to melanoma growth, oxidative stress, cellular senescence, and antitumor immunity.
#Summary ⬇️
bit.ly/46EmcYs
#Cancer #Melanoma
🌐 Visit Oncotarget.org to read #Blog synopses of new and #Trending research papers published by #Oncotarget.
#OA #PeerReviewed #Oncology #Cancer #Research #Science #MedEd
🧬 #BehindtheStudy:
Dr. Benoit Chabot discusses “The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response”
🎥 oncotarget.com/videos/interv…
#interview #author #research
📰 Stay updated with the latest #Oncotarget announcements and #PressReleases:
oncotarget.com/news/pr/
#OA #PeerReviewed #Oncology #Cancer #Research
✅ Read a #blog summary about the #research paper, titled "Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells."
#Summary ⬇️
oncotarget.org/2025/05/21/en…
#cancer #glioblastoma #braincancer #oa
🔎 Over 26,000 Oncotarget papers are now searchable on #PubMed:
pubmed.ncbi.nlm.nih.gov/?ter…
#publishing #cancer #research #openaccess #peerreviewed #journalpublication
